These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24239278)

  • 1. p27 and BCL2 expression predicts response to chemotherapy in head and neck squamous cell carcinomas.
    Moreno-Galindo C; Hermsen M; García-Pedrero JM; Fresno MF; Suárez C; Rodrigo JP
    Oral Oncol; 2014 Feb; 50(2):128-34. PubMed ID: 24239278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein levels of p21, p27, cyclin E and Bax predict sensitivity to cisplatin and paclitaxel in head and neck squamous cell carcinomas.
    Taguchi T; Kato Y; Baba Y; Nishimura G; Tanigaki Y; Horiuchi C; Mochimatsu I; Tsukuda M
    Oncol Rep; 2004 Feb; 11(2):421-6. PubMed ID: 14719078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic implication of the expression of EGFR, p53, cyclin D1, Bcl-2 and p16 in primary locally advanced oral squamous cell carcinoma cases: a tissue microarray study.
    Solomon MC; Vidyasagar MS; Fernandes D; Guddattu V; Mathew M; Shergill AK; Carnelio S; Chandrashekar C
    Med Oncol; 2016 Dec; 33(12):138. PubMed ID: 27817107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin-induced growth arrest of head and neck cancer cells correlates with increased expression of p16 and p53.
    Yip HT; Chopra R; Chakrabarti R; Veena MS; Ramamurthy B; Srivatsan ES; Wang MB
    Arch Otolaryngol Head Neck Surg; 2006 Mar; 132(3):317-26. PubMed ID: 16549753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
    Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
    Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical biomarkers and FDG uptake on PET/CT in head and neck squamous cell carcinoma.
    Rasmussen GB; Vogelius IR; Rasmussen JH; Schumaker L; Ioffe O; Cullen K; Fischer BM; Therkildsen MH; Specht L; Bentzen SM
    Acta Oncol; 2015; 54(9):1408-15. PubMed ID: 26256482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.
    Baschnagel AM; Williams L; Hanna A; Chen PY; Krauss DJ; Pruetz BL; Akervall J; Wilson GD
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):701-7. PubMed ID: 24521684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53, p16 and cyclin D1: molecular determinants of radiotherapy treatment response in oral carcinoma.
    Jayasurya R; Francis G; Kannan S; Lekshminarayanan K; Nalinakumari KR; Abraham T; Abraham EK; Nair MK
    Int J Cancer; 2004 May; 109(5):710-6. PubMed ID: 14999779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential biomarker expression in head and neck cancer correlates with anatomical localization.
    Tamás L; Szentkúti G; Eros M; Dános K; Brauswetter D; Szende B; Zsákovics I; Krenács T
    Pathol Oncol Res; 2011 Sep; 17(3):721-7. PubMed ID: 21487776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different patterns of expression of cell cycle control and local invasion-related proteins in oral squamous cell carcinoma affecting young patients.
    Miranda Galvis M; Santos-Silva AR; Freitas Jardim J; Paiva Fonseca F; Lopes MA; de Almeida OP; Lópes Pinto CA; Kaminagakura E; Sawazaki-Calone I; Speight PM; Kowalski LP
    J Oral Pathol Med; 2018 Jan; 47(1):32-39. PubMed ID: 28626969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck.
    Fouret P; Temam S; Charlotte F; Lacau-St-Guily J
    Br J Cancer; 2002 Dec; 87(12):1390-5. PubMed ID: 12454767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma.
    Miyazaki T; Kato H; Faried A; Sohda M; Nakajima M; Fukai Y; Masuda N; Manda R; Fukuchi M; Ojima H; Tsukada K; Kuwano H
    Anticancer Res; 2005; 25(4):2749-55. PubMed ID: 16080521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of expression of the CIP/KIP cell-cycle inhibitors p21 and p27 in laryngeal cancer.
    Pruneri G; Pignataro L; Carboni N; Buffa R; Di Finizio D; Cesana BM; Neri A
    J Clin Oncol; 1999 Oct; 17(10):3150-9. PubMed ID: 10506612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological response of cisplatin predicts patients' survival in oesophageal cancer and p53 protein accumulation in pretreatment biopsy is associated with cisplatin sensitivity.
    Shimada Y; Watanabe G; Yamasaki S; Maeda M; Kawabe A; Kaganoi JI; Itami A; Fukumoto M; Kanda Y; Imamura M
    Eur J Cancer; 2000 May; 36(8):987-93. PubMed ID: 10885602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Cell Cycle-related Proteins p16, p27 and Ki-67 Proliferating Marker in Laryngeal Squamous Cell Carcinomas and in Laryngeal Papillomas.
    Ciesielska U; Zatonski T; Nowinska K; Ratajczak-Wielgomas K; Grzegrzolka J; Piotrowska A; Olbromski M; Pula B; Podhorska-Okolow M; Dziegiel P
    Anticancer Res; 2017 May; 37(5):2407-2415. PubMed ID: 28476808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alterations of cell cycle regulating proteins: Rb, p21 and p16 in laryngeal cancer].
    Pietruszewska W; Durko M; Kobos J
    Otolaryngol Pol; 2007; 61(6):951-7. PubMed ID: 18546941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype.
    Rampias T; Pectasides E; Prasad M; Sasaki C; Gouveris P; Dimou A; Kountourakis P; Perisanidis C; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A
    Ann Oncol; 2013 Aug; 24(8):2124-31. PubMed ID: 23406730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of six gene proteins in laryngeal carcinomas and their significance].
    Wu X; He S; Wu M; Zhou L
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jul; 19(14):648-51. PubMed ID: 16248464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AQP1, AQP5, Bcl-2 and p16 in pharyngeal squamous cell carcinoma.
    Lehnerdt GF; Bachmann HS; Adamzik M; Panic A; Köksal E; Weller P; Lang S; Schmid KW; Siffert W; Bankfalvi A
    J Laryngol Otol; 2015 Jun; 129(6):580-6. PubMed ID: 26074259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy.
    Gasparini G; Bevilacqua P; Bonoldi E; Testolin A; Galassi A; Verderio P; Boracchi P; Guglielmi RB; Pezzella F
    Clin Cancer Res; 1995 Nov; 1(11):1375-83. PubMed ID: 9815934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.